Sjs Investment Consulting Inc. Agios Pharmaceuticals, Inc. Transaction History
Sjs Investment Consulting Inc.
- $540 Million
- Q4 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 9 shares of AGIO stock, worth $302. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 6
50.0%
Holding current value
$302
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$190 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$186 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$163 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$126 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$95.2 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.84B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...